Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
August 2005
in “The Journal of Clinical Endocrinology and Metabolism”
TLDR Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.
The document from 2005 estimates the economic burden of polycystic ovary syndrome (PCOS) in reproductive-aged women in the United States to be over $4 billion annually. The costs are primarily due to the treatment of associated conditions such as type 2 diabetes mellitus (DM), menstrual dysfunction/abnormal uterine bleeding (AUB), infertility, and hirsutism. The study suggests that widespread screening for PCOS could be cost-effective, potentially leading to earlier diagnosis and intervention, and reducing the economic burden. The document emphasizes that the costs calculated are conservative estimates and may be higher due to long-term morbidities associated with PCOS that emerge after the reproductive years.
View this study on academic.oup.com →
Cited in this study
research Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.
research Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.
research Prevalence of polycystic ovaries in women with androgenic alopecia
Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.
research Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.
research A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.
research Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.
research Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
PCOS affects a similar percentage of Black and White women in the Southeastern United States.
research A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia
Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.
Related
research Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.
research Polycystic ovary syndrome: Clinical aspects
The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.